Dolby Laboratories Reports Second Quarter Fiscal 2021 Financial Results

San Francisco, California, UNITED STATES


SAN FRANCISCO, May 04, 2021 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2021. For the second quarter, Dolby reported total revenue of $319.6 million, compared to $351.8 million for the second quarter of fiscal 2020.

"We continue to see growing momentum in the number of Dolby experiences being enabled by our partners across a broad range of content," said Kevin Yeaman, President and CEO, Dolby Laboratories. "We have expanded our reach within music and gaming, and Dolby.io is opening the door to bring Dolby to more content experiences."

Second quarter GAAP net income was $76.2 million, or $0.73 per diluted share, compared to GAAP net income of $88.5 million, or $0.86 per diluted share, for the second quarter of fiscal 2020. On a non-GAAP basis, second quarter net income was $94.8 million, or $0.91 per diluted share, compared to $106.6 million, or $1.04 per diluted share for the second quarter of fiscal 2020. Second quarter cash flows from operations was $83.5 million, compared to $65.7 million for the second quarter of fiscal 2020. A complete listing of Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release. 

COVID-19

Dolby continues to monitor the COVID-19 pandemic and its impact on our company. The safety and well-being of our employees and supporting our communities continue to be priorities. Since the initial outbreak of COVID-19, our revenue  continues to be impacted across various markets within licensing and products and services. The implications of COVID-19 on our future results of operations remain uncertain.

We expect continued uncertainty in global financial markets. Dolby’s financial results for the second quarter of fiscal 2021 rely on estimates of royalty-based revenue that take into consideration the macroeconomic effect of global events, including COVID-19, which may impact supply chain activities and consumer demand for electronic products.

Dividend

Today, Dolby announced a cash dividend of $0.22 per share of Class A and Class B common stock, payable on May 25, 2021, to stockholders of record as of the close of business on May 17, 2021.

Financial Outlook

The volume of shipments, aggregated across various end markets and devices, continues to be impacted and difficult to predict because of economic uncertainty due to COVID-19. The global cinema market has been adversely impacted by COVID-19, and it remains uncertain when and where cinemas will resume operating at full capacity.

Our actual results could differ materially from the estimates we are providing due in part to the challenging economic environment and highly uncertain effects of COVID-19. The estimates we are providing for future periods reflect certain assumptions about the potential impact of COVID-19, based upon a consideration of external and internal data and information. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that we face, and the section captioned "Risk Factors" in our Quarterly Report on Form 10-Q for the second quarter of fiscal 2021, filed on or around the date hereof.

Third Quarter Fiscal 2021

Dolby is providing the following estimates for its third quarter of fiscal 2021:

  • Total revenue is estimated to range from $260 million to $290 million
  • Gross margin percentages are anticipated to range from 88% to 89% on a GAAP basis and from 89% to 90% on a non-GAAP basis
  • Operating expenses are anticipated to range from $210 million to $220 million on a GAAP basis and from $185 million to $195 million on a non-GAAP basis
  • Effective tax rate is anticipated to range from 20% to 21% on both a GAAP and non-GAAP basis
  • Diluted earnings per share is anticipated to range from $0.15 to $0.30 on a GAAP basis and from $0.37 to $0.52 on a non-GAAP basis

Second Half of Fiscal 2021

Dolby is also providing the following estimate for its second half of fiscal 2021:

  • Total revenue is estimated to range from $560 million to $600 million

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss second quarter fiscal 2021 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Tuesday, May 4, 2021. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-833-789-1331 (or dialing 1-236-714-2740 for international callers), and entering confirmation code 9817368.

A replay of the call will be available from 5:00 p.m. PT on Tuesday, May 4, 2021, until 8:59 p.m. PT on Tuesday, May 11, 2021, by dialing 1-800-585-8367 (international callers can access the replay by dialing 1-416-621-4642) and entering the confirmation code 9817368. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby provides certain non-GAAP financial measures to provide investors with an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations. Specifically, we exclude the following as adjustments from one or more of our non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that we grant. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between our underlying operating results and those of other companies, we exclude stock-based compensation expense.

Amortization of acquisition-related intangibles: We amortize intangible assets acquired in connection with acquisitions. These intangible assets consist of patents and technology, customer relationships, and other intangibles. We record amortization charges relating to these intangible assets in our GAAP financial statements, and we view these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of our acquisitions. As these amortization charges do not directly correlate to our operations during any particular period, and often remain unchanged between reporting periods, we exclude these charges to facilitate an evaluation of our current operating results and comparisons to our past operating performance.

Restructuring charges: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. We exclude restructuring costs, including any adjustments to charges recorded in prior periods, as we believe that these costs are not representative of our normal operating activities and therefore, excluding these amounts enables a more effective comparison to our past operating performance.

Income tax adjustments: We believe that excluding the income tax effect of the aforementioned non-GAAP adjustments provides a more accurate view of our underlying operating results to management and investors.

Other operating income adjustments: We are excluding a one-time gain on the sale of property, which was previously classified as held for sale, finalized during the first quarter of fiscal 2021. The property was 51% owned by the controlling interest, therefore 51% of the gain recognized has been attributed to the controlling interest.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release, including, but not limited to, statements relating to Dolby's expected financial results for the third quarter and second half of fiscal 2021, our ability to advance our long-term objectives, and future dividend payments are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of COVID-19 on Dolby’s business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; consumer demand for products that incorporate Dolby technologies; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; the impact to the overall cinema market, including closures or limitations of cinema capacity and resulting adverse impact to Dolby’s revenue recognized on box-office sales and demand for cinema products and services; temporary Dolby office closures and other actions to protect Dolby’s workforce; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with trends in the markets in which Dolby operates, including the Broadcast, Mobile, Consumer Electronics, PC, Cinema, and Other Markets; the loss of, or reduction in sales by, a key customer or licensee; pricing pressures; risks that the continued shift in content distribution from optical disc-based and other traditional media to online and streaming media content could result in fewer devices with Dolby technologies or less revenue from such devices; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to the expiration of patents; the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative technologies in response to new and growing markets; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in our most recent quarterly report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sports and gaming, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide. We partner with artists, storytellers, developers, and businesses to revolutionize entertainment and communications with Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby.io.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby.io, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories, Inc. in the United States and/or other countries. Other trademarks remain the property of their respective owners. DLB-F



DOLBY LABORATORIES, INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts; unaudited)

 Fiscal Quarter Ended Fiscal Year-To-Date Ended
 March 26,
2021
March 27,
2020
 March 26,
2021
March 27,
2020
Revenue:     
Licensing$303,585  $328,865   $676,590  $586,548  
Products and services15,973  22,950   32,842  57,144  
Total revenue319,558  351,815   709,432  643,692  
      
Cost of revenue:     
Cost of licensing16,060  13,243   29,006  25,585  
Cost of products and services16,318  23,587   38,676  48,560  
Total cost of revenue32,378  36,830   67,682  74,145  
      
Gross margin287,180  314,985   641,750  569,547  
      
Operating expenses:     
Research and development65,808  60,086   129,580  117,736  
Sales and marketing78,046  88,485   153,491  183,603  
General and administrative59,398  60,800   113,852  113,329  
Gain on sale of assets     (13,871)   
Restructuring charges/(credits)741  (331)  10,764  344  
Total operating expenses203,993  209,040   393,816  415,012  
      
Operating income83,187  105,945   247,934  154,535  
      
Other income/(expense):     
Interest income962  4,721   1,936  9,653  
Interest expense(167) (25)  (252) (97) 
Other income, net1,385  138   2,711  1,142  
Total other income2,180  4,834   4,395  10,698  
      
Income before income taxes85,367  110,779   252,329  165,233  
Provision for income taxes(9,022) (22,105)  (33,294) (27,968) 
Net income including controlling interest76,345  88,674   219,035  137,265  
Less: net income attributable to controlling interest(128) (178)  (7,620) (16) 
Net income attributable to Dolby Laboratories, Inc.$76,217   $88,496    $211,415   $137,249   
      
Net income per share:     
Basic$0.75  $0.88   $2.09  $1.36  
Diluted$0.73  $0.86   $2.02  $1.33  
Weighted-average shares outstanding:     
Basic101,464  100,854   101,090  100,595  
Diluted104,581  102,773   104,414  103,133  



DOLBY LABORATORIES, INC.
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands; unaudited)

 March 26,
2021
September 25,
2020
ASSETS  
Current assets:  
Cash and cash equivalents$1,104,570  $1,071,876  
Restricted cash8,926  8,103  
Short-term investments58,582  46,948  
Accounts receivable, net283,505  180,340  
Contract assets, net233,379  161,357  
Inventories, net14,881  25,550  
Prepaid expenses and other current assets47,305  53,022  
Total current assets1,751,148  1,547,196  
Long-term investments42,188  52,149  
Property, plant, and equipment, net542,702  541,963  
Operating lease right-of-use assets71,976  76,515  
Goodwill and intangible assets, net475,179  489,376  
Deferred taxes135,551  118,881  
Other non-current assets87,546  91,245  
Total assets$3,106,290   $2,917,325   
   
LIABILITIES AND STOCKHOLDERS’ EQUITY  
Current liabilities:  
Accounts payable$8,385  $12,617  
Accrued liabilities254,163  219,974  
Income taxes payable11,087  3,260  
Contract liabilities20,029  15,436  
Operating lease liabilities15,313  15,822  
Total current liabilities308,977  267,109  
Non-current contract liabilities23,369  24,342  
Non-current operating lease liabilities61,165  65,315  
Other non-current liabilities118,559  122,154  
Total liabilities512,070  478,920  
   
Stockholders’ equity:  
Class A common stock59  58  
Class B common stock41  41  
Retained earnings2,591,870  2,443,138  
Accumulated other comprehensive loss(4,039) (10,594) 
Total stockholders’ equity – Dolby Laboratories, Inc.2,587,931  2,432,643  
Controlling interest6,289  5,762  
Total stockholders’ equity2,594,220  2,438,405  
Total liabilities and stockholders’ equity$3,106,290   $2,917,325   



DOLBY LABORATORIES, INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands; unaudited)

 Fiscal Year-to-Date Ended
 March 26,
2021
March 27,
2020
Operating activities:  
Net income including controlling interest$219,035  $137,265  
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization47,399  40,212  
Stock-based compensation50,726  43,565  
Amortization of premium on investments697  334  
Provision/(benefit) for credit losses(65) 2,955  
Deferred income taxes(16,992) (15,141) 
Gain on sale of assets(13,871)   
Other non-cash items affecting net income(1,847) 3,753  
Changes in operating assets and liabilities:  
Accounts receivable, net(102,791) (60,870) 
Contract assets(72,197) (28,086) 
Inventories10,398  (5,376) 
Operating lease right-of-use assets6,809  (20,102) 
Prepaid expenses and other assets10,552  (16,068) 
Accounts payable and accrued liabilities26,926  (21,431) 
Income taxes, net9,982  13,238  
Contract liabilities3,589  452  
Operating lease liabilities(6,987) 20,099  
Other non-current liabilities(5,735) 2,100  
Net cash provided by operating activities165,628  96,899  
   
Investing activities:  
Purchases of investment securities(26,449) (167,292) 
Proceeds from sales of investment securities4,594  109,907  
Proceeds from maturities of investment securities18,620  54,599  
Purchases of property, plant, and equipment(28,887) (41,782) 
Proceeds from sale of assets16,365    
Purchase of intangible assets  (2,640) 
Net cash used in investing activities(15,757) (47,208) 
   
Financing activities:  
Proceeds from issuance of common stock71,157  53,986  
Repurchase of common stock(110,775) (101,672) 
Payment of cash dividend(44,574) (44,336) 
Distribution to controlling interest(7,362) (283) 
Shares repurchased for tax withholdings on vesting of restricted stock(29,216) (21,094) 
Payment related to prior purchases of intangible assets  (91) 
Payment of deferred consideration for prior business combination  (3,000) 
Net cash used in financing activities(120,770) (116,490) 
   
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash4,416  (4,350) 
Net increase/(decrease) in cash, cash equivalents, and restricted cash33,517  (71,149) 
Cash, cash equivalents, and restricted cash at beginning of period1,079,979  805,593  
Cash, cash equivalents, and restricted cash at end of period$1,113,496  $734,444  



GAAP to Non-GAAP Reconciliations
(in millions, except per share data; unaudited)
      
The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the second quarter and year-to-date period ended March 26, 2021 and March 27, 2020:
      
Net income:Fiscal Quarter Ended Fiscal Year-To-Date Ended
 March 26,
2021
March 27,
2020
 March 26,
2021
March 27,
2020
GAAP net income$76.2  $88.5   $211.4  $137.2  
Stock-based compensation (1)24.4  21.0   50.7  43.6  
Amortization of acquisition-related intangibles (2)2.5  2.4   5.0  4.6  
Restructuring charges0.8  (0.3)  10.8  0.4  
Income tax adjustments(9.1) (5.0)  (23.0) (13.8) 
Other operating income adjustments     (6.8)   
Non-GAAP net income$94.8  $106.6   $248.1  $172.0  
      
(1) Stock-based compensation included in above line items:     
Cost of products and services$0.5  $0.5   $1.1  $1.0  
Research and development 7.2   6.2    15.1   13.2  
Sales and marketing 9.1   7.7    18.9   15.9  
General and administrative 7.6   6.6    15.6   13.5  
      
(2) Amortization of acquisition-related intangibles included in above line items:     
Cost of licensing$0.7  $1.1   $1.4  $1.7  
Cost of products and services0.9  0.8    1.8  1.2  
Research and development0.1  0.1    0.2  0.2  
Sales and marketing0.8  0.7    1.6  1.5  
General and administrative  (0.3)       
      
Diluted earnings per share:Fiscal Quarter Ended Fiscal Year-To-Date Ended
 March 26,
2021
March 27,
2020
 March 26,
2021
March 27,
2020
GAAP diluted earnings per share$0.73  $0.86   $2.02  $1.33  
Stock-based compensation0.24  0.21   0.49  0.43  
Amortization of acquisition-related intangibles0.02  0.02   0.04  0.04  
Restructuring charges0.01     0.11  0.01  
Income tax adjustments(0.09) (0.05)  (0.22) (0.13) 
Other operating income adjustments     (0.06)   
Non-GAAP diluted earnings per share$0.91  $1.04   $2.38  $1.68  
      
      
Shares used in computing diluted earnings per share105  103   104  103  
      
The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial amounts for the third quarter of fiscal 2021 included in this release:
      
Gross margin: Q3 2021   
GAAP gross margin (low - high end of range) 88% - 89%   
Stock-based compensation 0.4 %   
Amortization of acquisition-related intangibles 0.6 %   
Non-GAAP gross margin (low - high end of range) 89% - 90%   
      
Operating expenses: Q3 2021   
GAAP operating expenses (low - high end of range) $210 - $220   
Stock-based compensation (24)    
Amortization of acquisition-related intangibles (1)    
Non-GAAP operating expenses (low - high end of range) $185 - $195   
      
Diluted earnings per share:Q3 2021  
 LowHigh   
GAAP diluted earnings per share$0.15  $0.30     
Stock-based compensation0.24  0.24     
Amortization of acquisition-related intangibles0.03  0.03     
Income tax adjustments(0.05) (0.05)    
Non-GAAP diluted earnings per share$0.37  $0.52     
      
Shares used in computing diluted earnings per share104  104     


Investor Contact:
Jason Dea
Dolby Laboratories, Inc.
415-357-7002
investor@dolby.com

Media Contact:
Karen Hartquist
Dolby Laboratories, Inc.
415-505-8357
karen.hartquist@dolby.com